| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | U.S. economy not going into a recession; there are encouraging technical signals - Ryan Detrick | ||
| Do | Trump plan to cover weight loss meds in Medicare would cost insurers billions | ||
| Do | Cintas seen as 'compelling buy' as UniFirst results reinforce deal upside: UBS | ||
| Do | Vale raised to Buy at BofA as iron ore strength not reflected in share price | ||
| Do | SBAC Communications gains on report it's exploring a possible sale | ||
| Do | Lucid unveils 2027 Gravity lineup | ||
| Do | Next Hydrogen Solutions reports FY results | ||
| Do | YXT.com Group Holding reports FY results | ||
| Do | Quality Industrial reports FY results | ||
| Do | Touchstone Exploration Inc. GAAP EPS of $0.04, revenue of $11M | ||
| Do | Will sports betting operators turn to M&A as Kalshi and Polymarket keep taking market share? | ||
| Do | Current private credit issues are a correction, not a systematic rejection of the asset class - Oaktree Capital's Panossian | ||
| Do | Onward Medical N.V. reports FY results | ||
| Do | Freeport-McMoRan started Buy at Goldman as copper-gold leverage drives margin expansion | ||
| Do | Atlanta Fed lowers estimate for Q1 GDP growth as trade deficit weighs on economy | ||
| Do | Tango a new Buy at Canaccord Genuity on 2026 catalysts | ||
| Do | SpaceX has had talks with Saudi fund for potential $5B investment in IPO - report | ||
| Do | Palantir's ontology layer proves its moat, 'low' likelihood of AI disruption: UBS | ||
| Do | PAVS, IBG lead heavily shorted names in small, micro-cap consumer staples | ||
| Do | U.S. regulator sues three states over unlawful efforts to regulate prediction markets | ||
| Do | UK reaches agreement with US for British drugs to be tariff free | ||
| Do | Trump announces Pam Bondi stepping down as AG | ||
| Do | OpenAI acquires daily tech talk show TBPN to help support AI story | ||
| Do | Innocan Pharma reports FY results | ||
| Do | Nuveen Core Plus Impact Fund declares $0.099 dividend |